Milim Kim

Dr. Milim Kim

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2024 in Cancers
Verified
Journal Article
Open access
PDF file
HKHyungkyung Kim
Hyungkyung Kim
EHEunkyung Han
Eunkyung Han
JLJeonghyo Lee
Jeonghyo Lee
Kwangil YimKwangil Yim
Kwangil Yim
JAJamshid Abdul-Ghafar
Jamshid Abdul-Ghafar
Yosep ChongYosep Chong
Yosep Chong
Ascites cytology is a cost-effective test for metastatic colorectal cancer (CRC) in the abdominal cavity. However, metastatic carcinoma of the peritoneum is difficult to diagnose based on biopsy findings, and ascitic aspiration cytology has a low sensitivity and specificity and a high inter-observer variability. The aim of the present study was to apply artificial intelligence (AI) to classify benign and malignant cells in ascites cytology patch images of metastatic CRC using a deep convolutional neural network. Datasets were collected from The OPEN AI Dataset Project, a nationwide cytology dataset for AI research. The numbers of patch images used for training, validation, and testing were 56,560, 7068, and 6534, respectively. We evaluated 1041 patch images of benign and metastatic CRC in the ascitic fluid to compare the performance of pathologists and an AI algorithm, and to examine whether the diagnostic accuracy of pathologists improved with the assistance of AI. This AI method showed an accuracy, a sensitivity, and a specificity of 93.74%, 87.76%, and 99.75%, respectively, for the differential diagnosis of malignant and benign ascites. The diagnostic accuracy and sensitivity of the pathologist with the assistance of the proposed AI method increased from 86.8% to 90.5% and from 73.3% to 79.3%, respectively. The proposed deep learning method may assist pathologists with different levels of experience in diagnosing metastatic CRC cells of ascites.

20 August 2025 in Clinical Cancer Research
Verified
Journal Article
Closed access
SJSeung Hyuck Jeon
Seung Hyuck Jeon
KSKoung Jin Suh
Koung Jin Suh
SJSungmin Jung
Sungmin Jung
MJMinwoo Jeon
Minwoo Jeon
HJHo Cheol Jang
Ho Cheol Jang
ESEui-Cheol Shin
Eui-Cheol Shin
Purpose: PD-1/PD-L1 blockade modulates the responses of T cells, including regulatory T cells (Treg). Understanding the changes of Treg upon PD-1/PD-L1 blockade in patients with cancer and their association with therapeutic response will provide clues about the mechanisms underlying resistance to treatment. Experimental Design: Peripheral blood samples were acquired before and at 1 week following treatment from 65 patients [triple-negative (TN), n = 35; luminal, n = 30] enrolled in the KORNELIA phase II trial, which evaluated the efficacy of chemoimmunotherapy combining nivolumab and eribulin in patients with HER2-negative breast cancer. The immunophenotype of circulating immune cells was analyzed by flow cytometry. T-cell receptor sequencing was used to track the clonotypes of circulating Treg in relation to the tumor-related clonotypes. Results: In both breast cancer subtypes, chemoimmunotherapy increased the proportion of circulating Treg as well as their proliferative response. Notably, we observed an increased frequency of the circulating Treg population with tumor-related clonotypes after treatment in triple-negative breast cancer (TNBC). Moreover, increased proliferation of circulating Treg was associated with poor response to treatment, only in TNBC. This association between circulating Treg proliferation and poor clinical response was further supported by the analysis of publicly available single-cell transcriptomic data from patients with TNBC. A Treg-based biomarker predicted both clinical response and survival outcomes in TNBC. Conclusions: Our results indicate that the proliferation and expansion of tumor-related clonotypes among circulating Treg are related to chemoimmunotherapy resistance, particularly in TNBC.



3 November 2025
Verified
Other
Open access
SJSeung Hyuck Jeon
Seung Hyuck Jeon
KSKoung Jin Suh
Koung Jin Suh
SJSungmin Jung
Sungmin Jung
MJMinwoo Jeon
Minwoo Jeon
HJHo Cheol Jang
Ho Cheol Jang
ESEui-Cheol Shin
Eui-Cheol Shin
Table S3 from Proliferation of Tumor-Related Regulatory T Cells in Circulation Dictates Efficacy of Chemoimmunotherapy in Triple-Negative Breast Cancer

5 November 2022 in Breast Cancer
Verified
Journal Article
Open access
PDF file
JWJi Won Woo
Ji Won Woo
HCHye Yeon Choi
Hye Yeon Choi
MKMilim Kim
Milim Kim
YCYul Ri Chung
Yul Ri Chung
SPSo-Yeon Park
So-Yeon Park